Back

The role of TTR in ATTR-CM disease and treatment

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: What is the role of TTR in transthyretin amyloid cardiomyopathy? Cardiomyopathies Open Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Thibaud Damy

University Hospital Henri Mondor, Creteil (France)

5 More presentations in this session

Presentation thumbnail
Introduction
Doctor M. Maurer (New York, US)
Slides Video
Presentation thumbnail
Question & answers
Presentation thumbnail
The role of TTR as a surrogate marker in treatment of ATTR-CM
Doctor J. Gillmore (Greater London, GB)
Slides Video
Presentation thumbnail
Questions & answers
Presentation thumbnail
Summary, audience Q&A, panel discussion and closing of session
Professor T. Damy (Creteil, FR) Doctor M. Maurer (New York, US) Doctor J. Gillmore (Greater London, GB)
Slides Video

Access the full session

Session thumbnail
What is the role of TTR in transthyretin amyloid cardiomyopathy?
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Session
What is the role of TTR in transthyretin amyloid cardiomyopathy?
thumbnail
Congress Presentation
Transthyretin cardiac amyloidosis: pathophysiology and consequences
thumbnail
Congress Session
Treatment of transthyretin amyloidosis cardiomyopathy: on the path to a cure?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources